menu
Thrombectomy Devices Market To Surpass US$ 1.9 Billion By 2026 - Coherent Market Insights
Thrombectomy Devices Market To Surpass US$ 1.9 Billion By 2026 - Coherent Market Insights
“Coherent Market Insights “THROMBECTOMY DEVICES MARKET – GLOBAL TRENDS, ESTIMATES AND FORECASTS, 2020-2027?

The Global ThrombectomyDevices Market, by Product Type (Mechanical Thrombectomy Devices,Aspiration Thrombectomy Devices, Hydrodynamic Thrombectomy Devices, andUltrasonic Thrombectomy Devices), by Application (Neurovascular,Cardiovascular, and Peripheral Vascular), and by End User (Hospitals,Ambulatory Surgical Centers, and Research Laboratories and AcademicInstitutes), and by Region (North America, Latin America, Europe, Asia Pacific,Middle East, and Africa) was valued at US$ 1.03 billion in 2017, and isprojected to exhibit a CAGR of 7.4% during the forecast period (2018 - 2026).

 Thrombectomy procedure is indicated forpatients with acute ischemic stroke caused due to blockage in one or more largearteries in the brain. People already treated with intravenous thrombolysisthat has not been effective, can also be treated with the help of thrombectomyprocedures. Thrombectomy approaches have evolved rapidly due to risingtechnological advancements of catheters as well as thrombectomy device such asintra-arterial thrombolytic infusions, which enable higher recanalization ratesthan before. Manufacturers are focused on gaining maximum product approval andinnovating existing products in order to gain market share. In May 2018,Stryker Corporation received an expanded CE Mark approval in the European Unionfor its Trevo thrombectomy device as a front-line treatment for acute ischemicstroke patients.

* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2254

In August 2018, NexGen MedicalSystems, Inc., completed the first human use of their XCOIL Large Vessel (18mm)Thrombectomy System for the treatment of deep vein thrombosis (DVT). The newdevice, an expansion of the successful XCOIL 12mm System, is designed torapidly remove blood clots in large vessels, such as the iliac vein. In May2017, SurModics acquired Embolitech’s thrombectomy platform and the associatedintellectual property in a deal worth US$ 5 million, with additional paymentsbased on regulatory milestones.

Browse 30 Market Data Tables and33 Figures spread through 194 Pages and in-depth TOC on "ThrombectomyDevices Market, by Product Type (Mechanical Thrombectomy Devices, AspirationThrombectomy Devices, Hydrodynamic Thrombectomy Devices, and UltrasonicThrombectomy Devices), by Application (Neurovascular, Cardiovascular, andPeripheral Vascular), and by End User (Hospitals, Ambulatory Surgical Centers,and Research Laboratories and Academic Institutes), and by Region (NorthAmerica, Latin America, Europe, Asia Pacific, Middle East, and Africa) - GlobalForecast to 2026"

Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/thrombectomy-devices-market-2254

Key Takeaways of the thrombectomydevices Market:

The global thrombectomy devicesmarket is expected to expand at a CAGR of 7.4% during the forecast period(2018–2026), owing to increasing incidence of stroke and thrombosis, and risingtechnological advancement in thrombectomy devices. For instance, in 2016,Penumbra Inc., announced the U.S. commercial availability of its most advancedthrombectomy device, ACE68 Reperfusion Catheter. The product leverages thelatest advancements in tracking technology to deliver maximum aspiration powereasily and safely for extracting thrombus in acute ischemic stroke patients.

Major players operating in theglobal thrombectomy devices market include Applied Medical, Argon MedicalDevices, Inc., Boston Scientific Corporation, BTG International, CaptureVascular, Claret Medical, Control Medical Technology, Edwards LifesciencesCorporation, Johnson & Johnson, Medtronic PLC, Merit Medical Systems, Inc.,Minnetronix, Inc., Nexgen Medical Systems, Inc., Natec Medical Ltd., Penumbra,Inc., Phenox GmbH, Stentys SA, Spectranetics Corporation, Straub Medical AG,Stryker Corporation, Terumo Corporation, and Teleflex Incorporated.

Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2254

AboutCoherent Market Insights:            

CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.

ContactUs:

mailto:sales@coherentmarketinsights.com

U.S.Office:

Name:  Mr. Shah

CoherentMarket Insights 1001 4th Ave,

# 3200Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN:  +050-5539-1737